Uterine Leiomyomas, also called flbroids, are the most common pelvic tumors in women and it is well accepted that estrogen plays an important role in the growth and development of leiomyomas. Genetic factors, such as chromosomal abnormalitites HMGA 1 and HMGA 2, have been found to be increased in not only uterine leiomyomas but also in other hormone related diseases such as prostate, cervical, and breast cancer. Though HMGA 1 and HMGA 2 are linked to hormone dependent carcinomas, their correlation with estrogen is yet unknown. Therefore in this proposal, we first want to establish that estrogen regulates HMGA's in uterine leiomyomas. We then plan to investigate the effects of environmental estrogens and the molecular mechanisms underlying estrogen's role in the development/regulation of uterine leiomyomas through HMGA's.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31CA103365-02
Application #
6784600
Study Section
Special Emphasis Panel (ZRG1-MBC-1 (29))
Program Officer
Bini, Alessandra M
Project Start
2003-06-23
Project End
2005-06-22
Budget Start
2004-08-01
Budget End
2005-06-22
Support Year
2
Fiscal Year
2004
Total Cost
$27,418
Indirect Cost
Name
Tulane University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118